Experimental HIV vaccine aims to boost immune control in treated patients
Disease control
Completed
This early-stage trial tested a therapeutic DNA vaccine called ICVAX in 45 adults with HIV who were already on stable antiretroviral therapy (ART). The goal was to see if the vaccine is safe and can strengthen the body's immune response against HIV. Participants received either t…
Phase: PHASE1 • Sponsor: Immuno Cure Holding (HK) Limited • Aim: Disease control
Last updated May 17, 2026 02:36 UTC